Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
This is a fascinating article. The potential market value of CZT products is huge. I have always wondered why Kromek is not an M&A target for bigger players? Especially as the share price is so depressed against a proposed fair value. I appreciate there are three business models are play for Kromek, but the upside in this vertical is huge and the IP surely carries great value to bigger organisations. They could target Kromek for this IP, and then just spin out the other two business models if it so wanted. Anyone else thought about Kromek maybe being a target and why no one has moved on it?
If this funded development Breast imaging project come good
as it's looking increasingly likely it will, it's a company maker on its own I think.worth more than the present share price.
Low-Dose Molecular Breast Imaging (MBI) Could Improve Cancer Detection in Dense Breast Tissue.
https://www.medimaging.net/general-imaging/articles/294796139/low-dose-molecular-breast-imaging-mbi-could-improve-cancer-detection-in-dense-breast-
tissue.html#amp_tf=From%20%251%24s&aoh=16993944765823&referrer=https%3A%2F%2Fwww.google.com&share=https%3A%2F%2Fwww.medimaging.net%2Fgeneral-imaging%2Farticles%2F294796139%2Flow-dose-molecular-breast-imaging-mbi-could-improve-cancer-detection-in-dense-breast-tissue.html
All the recent medical imaging CZT contracts and design development deals have all mentioned the same phrase from memory...'with assured CZT manufacturing capacity for future production sales'
Sounds to me like Thier timing to ramp up CZT furnace capacity was well timed and a few more tier 2's might decide sooner than later to secure thier place on the growing preferential customers list..all good news to me.
Yet again great news stories here. The sp up one day and then back down. Just above 5p as i write. Seems few believe the latest "claims" of wonderful wealth making contracts. Wake up it is still just Smoke and Mirrors or there are numerous idiots failing to cash in as the sp will soon be 4x to-days price.
Plus -
On 31 October Kromek announced 3 more orders for CBRN detection worth a total of US$1.0m (£0.82m), most of which is expected to be recognised in the current year to 30 April 2024. Then on 7 November the Group announced a collaboration agreement with a new blue chip partner for CZT-based photon-counting CT medical applications; the partner provides solutions to over 100,000 customers globally.
Kromek had also announced the refinancing of its HSBC RCF in September and our outlook remains unchanged: indicative of a FY25 E EV/EBITDA multiple of 6.8x. As does our Fair Value at 26p / share.
Still in bombed out territory here sadly, and news on £££ for the latest CT medical deals with put a rocket under these I think...the deals are all stacking up nicely
Links a bit flakey for me
"Bio-detection becomes a commercial reality"
Recent new contracts show that Kromek’s investment in bio-hazard detection technology is becoming a commercial reality. On 26 October the Group received a US$5.9m (£4.84m) contract from the US Department of Homeland Security Countering Weapons of Mass Destruction (CWMD) Office - the first for Kromek - to research and develop technologies for agent-agnostic bio-detection.
After a strong run of encouraging news our positive outlook remains unchanged - as does Fair Value at 26p / share.
Read/hear new research note here (free access):
https://equitydevelopment.co.uk/research/bio-detection-becomes-a-commercial-reality
Yes, not know what kind of partnership contracts and model.
Any in public domain to research?
if long term,sticky and good financial terms, that will be good.
And not sure if KMK invests into them monetarily or just imparts technology and resources and what / when returns. Hope for good
Yeah. All good. Just seams strange that all the companies that KMk team up with seem to benefit more than kmk do.
Kromek teams up to use CZT technology to develop photon-counting CT scanners | AIM:KMK
https://www.proactiveinvestors.co.uk/companies/news/1032275/kromek-teams-up-to-use-czt-technology-to-develop-photon-counting-ct-scanners-1032275.html
Seems promising news, although collaboration partner not named, RNS mentions that "as the project is progressing towards commercialisation..", so looks safe to assume that perhaps none in short term but (hopefully) likely to fructify in the mid-term and fairly good potential, like to know who is this partner.
@ notsofastyou.
Most of us have been done with this share. Good luck
Nov 3rd - twitter kmk
"Over the past two days, we've had the pleasure of welcoming customers from Saudi Arabia to our HQ in County Durham."
Exchanging product and industry knowledge, as well as taking part in-depth product training; it's been a valuable visit for all.
a new customer by the look of it...
Well, pedro. This little spike is in perfect sinc with the ten year trend line. This needs a lot of headway here to breakout. I hope your assessment/assumptions come good but don’t hold your breath. This drop today could be……
Yep. I’d have sold out at this price and broke even if I hadn’t given up 2 days before Simon Thomson released his latest pump. Maybe it will go somewhere who knows but I’m done with this share.
Keep calm Pedro and co . The SP has only got back to its March value which it reached after a crash.r
I'd agree on the interest front. If we are not planning to pay the interest and are issuing new shares we want the price to be flying. We ended the trading period to the 30th October on Monday. It'll be interesting to see if we issue a trading update. If the results are as favourable as some posters suggest this should be out sooner rather than later.... We will see...
Motoring now....Up it goes....and no wonder....This is worth 20p plus......We are profitable and the previous risk of dilution has gone,with the increasing orders now making this a compelling investment.....rerate only just started....
Well, good news for current holders is its stops so much dilution if KMK decide to give shares rather than interest.
I gave up reading IC a long time ago, it cost me an arm and a leg following it and perhaps especially ST. I have learnt to take various tipsters with a huge bag of salt, they seem wrong more often than not and especially in a flat or falling general market.
There is plenty of evidence to the contrary and not much supporting what you say.
Pedro. Your morse code blogs are missing a few dashes. Wonder if ST can advise.
20p seems realistic....Sales set to start rising,and profit now being made....All the risk profile of this share is history and the s,p should start to represent the true value....20p in a year ,I think....
I am not sure that the chart tells us very much. It could mean the price has bottomed and there will be a swift rise in price. The short term chart suggests that. It could mean that the price will spike in the short term and there will then be a further collapse and period of decline. The longer term chart suggests this. I hate to sound like a cracked record but a number of meaningful sales is the only thing that will drive this share up and reduce the current lack of trust of the company's management - unless the management changes and sentiment improves that way, of course.